ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
15.85
-0.42 (-2.58%)
Nov 21, 2024, 11:34 AM EST - Market open
ACADIA Pharmaceuticals Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$26.44
Upside
+66.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +76.66% | Nov 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +70.35% | Nov 7, 2024 |
| Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $23 | Strong Buy | Maintains | $30 → $23 | +45.11% | Aug 8, 2024 |
| UBS | UBS | Strong Buy Maintains $25 → $23 | Strong Buy | Maintains | $25 → $23 | +45.11% | Aug 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $27 | Strong Buy | Reiterates | $27 | +70.35% | Aug 8, 2024 |
| Needham | Needham | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +76.66% | Aug 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $37 → $28 | Buy | Maintains | $37 → $28 | +76.66% | Aug 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $29 → $26 | Buy | Maintains | $29 → $26 | +64.04% | Aug 7, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $28 → $20 | Buy → Hold | Downgrades | $28 → $20 | +26.18% | Aug 7, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +76.66% | Jul 12, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $31 | Buy | Initiates | $31 | +95.58% | Jun 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $29 | Buy | Reiterates | $29 | +82.97% | Jun 25, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $26 → $22 | Hold | Maintains | $26 → $22 | +38.80% | May 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +89.27% | May 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $37 | Buy | Reiterates | $37 | +133.44% | May 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.